13F HOLDINGS REPORT
Mayo Clinic
Quarter ended Q1 2024 · Filed May 13, 2024 · Accession 0000950123-24-004535
Total Value
$6.1M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Zentalis Pharmaceuticals Inc. | ZNTL | 187,143 | $2.9M | 48.00% |
| 2 | MSCI ACWI ETF | 464288257 | 17,359 | $1.9M | 31.11% |
| 3 | Perspective Therapeutics Inc. | CATX | 724,641 | $862,323 | 14.03% |
| 4 | Neuroone Medical Technologies | 64130M209 | 181,754 | $218,105 | 3.55% |
| 5 | UNITY BIOTECHNOLOGY INC | UNTCW | 124,081 | $203,493 | 3.31% |